These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12478500)

  • 1. Anticoagulants: to bleed or not to bleed, that is the question.
    Da Silva MS; Sobel M
    Semin Vasc Surg; 2002 Dec; 15(4):256-67. PubMed ID: 12478500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of anticoagulants].
    Oger E; Mottier D
    Presse Med; 2000 May 27-Jun 3; 29(19):1079-82. PubMed ID: 10874921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor Xa inhibitors: new anti-thrombotic agents and their characteristics.
    Ieko M; Tarumi T; Nakabayashi T; Yoshida M; Naito S; Koike T
    Front Biosci; 2006 Jan; 11():232-48. PubMed ID: 16146728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of venous thromboembolism after treatment with unfractionated heparin.
    Sutton SK
    Ann Intern Med; 1996 Mar; 124(5):532. PubMed ID: 8602716
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulants in clinical practice].
    Boneu B
    Rev Prat; 1999 Oct; 49(15):1641-7. PubMed ID: 10581994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed thrombin generation with hirudin anticoagulation during prolonged cardiopulmonary bypass.
    Rubens FD; Lavalee G; Ruel MA; Mesana T; Bourke M
    Ann Thorac Surg; 2005 Jan; 79(1):334-6. PubMed ID: 15620975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
    Bartholomew JR
    Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
    Laposata M; Green D; Van Cott EM; Barrowcliffe TW; Goodnight SH; Sosolik RC
    Arch Pathol Lab Med; 1998 Sep; 122(9):799-807. PubMed ID: 9740137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulant therapy in pulmonary embolism].
    Charbonnier B; Pacouret G; Augusseau-Richard MP; Dessenne X; Pagot O
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11 Suppl):1755-61. PubMed ID: 8815836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New antithrombotic drugs (excluding plasminogen activators].
    Lecompte T
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1225-32. PubMed ID: 11794963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery.
    Merry AF
    Semin Thromb Hemost; 2004 Jun; 30(3):337-46. PubMed ID: 15282656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia.
    Giannubilo SR; Tranquilli AL
    Curr Med Chem; 2012; 19(27):4562-71. PubMed ID: 22876895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
    Boneu B
    Haemostasis; 1996 Oct; 26 Suppl 4():368-78. PubMed ID: 8979141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
    Hassell K
    Chest; 2005 Feb; 127(2 Suppl):1S-8S. PubMed ID: 15706025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation in continuous renal replacement therapy.
    Vargas Hein O; Kox WJ; Spies C
    Contrib Nephrol; 2004; 144():308-16. PubMed ID: 15264419
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis of APC resistance in patients on standard or low molecular weight heparin.
    Gilmore G; Thom J; Baker RI
    Thromb Haemost; 1996 Feb; 75(2):372-3. PubMed ID: 8815593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.